Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Net Margin: 2012-2024

Historic Net Margin for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to -14.72%.

  • Sunshine Biopharma's Net Margin rose 1734.00% to 3.14% in Q3 2025 from the same period last year, while for Sep 2025 it was -16.06%, marking a year-over-year increase of 66.00%. This contributed to the annual value of -14.72% for FY2024, which is 398.00% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Net Margin of -14.72% as of FY2024, which was up 21.29% from -18.70% recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Net Margin registered a high of -14.72% during FY2024, and its lowest value of -5,444.41% during FY2021.
  • In the last 3 years, Sunshine Biopharma's Net Margin had a median value of -18.70% in 2023 and averaged -216.29%.
  • As far as peak fluctuations go, Sunshine Biopharma's Net Margin tumbled by 154,567bps in 2021, and later spiked by 482,897bps in 2022.
  • Over the past 5 years, Sunshine Biopharma's Net Margin (Yearly) stood at -3,898.74% in 2020, then crashed by 154,567bps to -5,444.41% in 2021, then soared by 482,897bps to -615.44% in 2022, then spiked by 59,673bps to -18.70% in 2023, then surged by 398bps to -14.72% in 2024.